Decreased expression of EIF4A1 after preoperative brachytherapy predicts better tumor-specific survival in cervical cancer

International Journal of Gynecological Cancer

Volumn 24, Issue 5, 2014, Pages 908-915

  Liang, Shanhui ^a,b   Zhou, Yuqi ^a,b   Chen, Yiran ^a,b   Ke, Guihao ^a,b   Wen, Hao ^a,b   Wu, Xiaohua ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Brachytherapy; Cervical cancer; EIF4A1; EIF4F; Prognosis; Translational control

Indexed keywords

INITIATION FACTOR 4A; INITIATION FACTOR 4A 1; INITIATION FACTOR 4E; INITIATION FACTOR 4G; INITIATION FACTOR 4G 1; UNCLASSIFIED DRUG; EIF4G1 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; TISSUE MICROARRAY; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX; UTERINE CERVIX CANCER; CANCER GRADING; CARCINOMA, SQUAMOUS CELL; ENZYME IMMUNOASSAY; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; SECONDARY; STROMA CELL; SURVIVAL RATE; TUMOR INVASION; UTERINE CERVICAL NEOPLASMS;

BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; EUKARYOTIC INITIATION FACTOR-4A; EUKARYOTIC INITIATION FACTOR-4E; EUKARYOTIC INITIATION FACTOR-4G; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PREOPERATIVE CARE; PROGNOSIS; STROMAL CELLS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84904110996     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000152     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. Ca Cancer J Clin. 2011;61:69-90.
2. Hagner PR, Schneider A, Gartenhaus RB. Targeting the translational machinery as a novel treatment strategy for hematologic malignancies. Blood. 2010;18:2127-2135.
3. Mamane Y, Petroulakis E, Rong L, et al. eIF4EVfrom translation to transformation. Oncogene. 2004;19:3172-3179.
4. Fukuchi-Shimogori T, Ishii I, Kashiwagi K, et al. Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res. 1997;57:5041-5044.
5. Shuda M, Kondoh N, Tanaka K, et al. Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res. 2000;20:2489-2494.
6. Eberle J, Krasagakis K, Orfanos CE. Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer. 1997;71:396-401.
7. Wang S, Rosenwald IB, Hutzler MJ, et al. Expressionof the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol. 1999;155:247-255.
8. Kerekatte V, Smiley K, Hu B, et al. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int J Cancer. 1995;64:27-31.
9. Rosenwald IB, Hutzler MJ, Wang S, et al. Expression of eukaryotic translation initiation factors 4E and 2alpha is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung. Cancer. 2001;92:2164-2171.
10. Nathan CO, Amirghahari N, Abreo F, et al. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Clin Cancer Res. 2004;10:5820-5827.
11. Salehi Z, Mashayekhi F. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer. Clin Biochem. 2006;39:404-409.
12. Salehi Z, Mashayekhi F, Shahosseini F. Significance of eIF4E expression in skin squamous cell carcinoma. Cell Biol Int. 2007;31:1400-1404.
13. CrewJP, Fuggle S,BicknellR, et al. Eukaryotic initiation factorY4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression. Br J Cancer. 2000;82:161-166.
14. Rosenwald IB, Chen JJ, Wang S, et al. Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis. Oncogene. 1999;18:2507-2517.
15. Matthews-Greer J, Caldito G, De Benedetti A, et al. eIF4E as a marker for cervical neoplasia. Appl Immunohistochem Mol Morphol. 2005;13:367-370.
16. Bordeleau ME, Robert F, Gerard B, et al. Therapeutic suppression of translation initiation modulates chemosensitivity in amouse lymphomamodel. JClin Invest. 2008;118:2651-2660.
17. Hayman TJ, Williams ES, Jamal M, et al. Translation initiation factor eIF4E is a target for tumor cell radiosensitization. Cancer Res. 2012;72:2362-2372.
18. Tu L, Liu Z, He X, et al. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Mol Cancer. 2010;9:78.
19. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847.
20. WHO. Handbook for Reporting Results of Cancer Treatment. Geneva:WHOOffset Publication; Geneva, Switzerland. 1979:48.
21. Svitkin YV, Pause A, Haghighat A, et al. The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5¶ secondary structure. RNA. 2001;7:382-394.
22. KozakM.Ananalysis of 5¶-noncoding sequences from699 vertebrate messenger RNAs. Nucleic Acids Res. 1987;15:8125-8148.
23. Lomnytska MI, Becker S, Gemoll T, et al. Impact of genomic stability on protein expression in endometrioid endometrial cancer. Br J Cancer. 2012;27:1297-1305.
24. JiP, Diederichs S,WangW, et al.MALAT-1, a novel noncodingRNA, and thymosin beta 4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22:8031-8041.
25. VanTrappenPO,RyanA,Carroll M, et al.Amodel for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer. 2002;87:537-544.
26. Lee JW, Choi JJ, Lee KM, et al. eIF-4E expression is associated with histopathologic grades in cervical neoplasia. Hum Pathol. 2005;36:1197-1203.
27. Silvera D, Arju R, Darvishian F, et al. Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol. 2009;11:903-908.
28. Bauer C, Brass N, Diesinger I, et al. Overexpression of the eukaryotic translation initiation factor 4G (eIF4G-1) in squamous cell lung carcinoma. Int J Cancer. 2002;98:181-185.
29. Bauer C, Diesinger I, Brass N, et al. Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma. Cancer. 2001;92: 822-829.